**Core Concept**
Cooley's anemia is a congenital disorder of hemoglobin synthesis, characterized by the production of abnormal hemoglobin (HbS or HbF) due to mutations in the HBB gene. This leads to chronic hemolysis, anemia, and other complications.

**Why the Correct Answer is Right**
The correct answer is linked to the pathophysiology of Cooley's anemia, which involves the production of abnormal hemoglobin. The HBB gene encodes the beta-globin subunit of hemoglobin, and mutations in this gene lead to the production of abnormal hemoglobin. This results in chronic hemolysis, anemia, and other complications associated with Cooley's anemia.

**Why Each Wrong Option is Incorrect**
**Option A:** Beta-thalassemia is a related condition, but it is not the other name for Cooley's anemia. Beta-thalassemia is characterized by reduced production of the beta-globin subunit of hemoglobin, whereas Cooley's anemia is characterized by the production of abnormal hemoglobin.
**Option B:** Sickle cell disease is a different condition that affects the production of hemoglobin, but it is not the other name for Cooley's anemia. Sickle cell disease is caused by a mutation in the HBB gene that leads to the production of abnormal hemoglobin (HbS), whereas Cooley's anemia is caused by mutations in the HBB gene that lead to the production of abnormal hemoglobin (HbF).
**Option C:** Alpha-thalassemia is a different condition that affects the production of the alpha-globin subunit of hemoglobin, and it is not the other name for Cooley's anemia.

**Clinical Pearl / High-Yield Fact**
Cooley's anemia is also known as beta-thalassemia major, and it is characterized by severe anemia, jaundice, and other complications. It is essential to diagnose and manage Cooley's anemia early to prevent long-term complications.

**Correct Answer:** D.